Abstract
Background. In the case of DNA-aneuploid tumors there are no clear guidelines as to which S-phase fraction is the more relevant one: that corresponding to either the diploid or the aneuploid population, or rather an average of both.
Materials and methods. We studied 280 breast cancer specimens from previously untreated patients. Histologically, 231 were ductal infiltrating carcinomas, 30 lobular infiltrating carcinomas and 19 corresponded to other, less frequent varieties. Postsurgically, 164 cases (58.6%) were classified as T1, 87 (31.1%) as T2 and 7 as T3. The remaining 22 cases were multifocal, diffuse tumors. Flow cytometry was performed on fresh tumor tissue, and immunohistochemistry for hormone receptors, Ki67, c-erb-B2 and p53 on paraffin-embedded material.
Results. In diploid tumors, a high S-phase (above the 75th percentile) correlated significantly with Ki67 expression ≥20% (p<0.0001). In aneuploid tumors, however, this was only the case for the aneuploid fraction of tumor cells (p<0.0001). A high S-phase of diploid tumors correlated directly and significantly with a high histologic grade (p=0.04), a high nuclear grade (p=0.01), tumor size (p=0.0008), and inversely with estrogen (p<0.0001) and progesterone (p<0.0001) receptor expression. In aneuploid tumors, the aneuploid tumor fraction showed a direct and significant correlation with a high histologic grade (p=0.005), a high nuclear grade (p=0.001), mutant p53 expression (p=0.0009), and inversely with estrogen (p<0.0001) and progesterone (p=0.0001) receptor expression. A high S-phase of the diploid cell fraction of aneuploid tumors, on the other hand, just showed an inverse correlation with high nuclear grade of the tumors (p=0.02), and none whatsoever with all other tested parameters.
Similar content being viewed by others
References
RS Camplejohn CM Ash CE Gillett B Raikundalia DM Barnes WM Gregory MA Richards RR Millis (1995) ArticleTitleThe prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre Br J Cancer 71 140–145 Occurrence Handle1:STN:280:ByqC3MfnvVI%3D Occurrence Handle7819030
A Chassevent ML Jourdan S Romain F Descotes M Colonna PM Martin M Bolla F Spyratos (2001) ArticleTitleS-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study Clin Cancer Res 7 909–917 Occurrence Handle1:CAS:528:DC%2BD3MXjs1elsLc%3D Occurrence Handle11309341
DW Hedley GM Clark CJ Cornelisse D Killander T Kute D Merkel (1993) ArticleTitleDNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast Breast Cancer Res Treat 28 55–59 Occurrence Handle10.1007/BF00666357 Occurrence Handle1:STN:280:ByuC28bjvFw%3D Occurrence Handle8123870
TE Kute Y Quadri H Muss N Zbieranski C Cirrincione DA Berry M Barcos AP Thor E Liu F Koerner (1995) ArticleTitleFlow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869 Cytometry 22 297–306 Occurrence Handle1:STN:280:BymA2MnjvVM%3D Occurrence Handle8749780
O Stal M Dufmats T Hatschek J Carstensen C Klintenberg LE Rutqvist L Skoog S Sullivan S Wingren B Nordenskjold (1993) ArticleTitleS-phase fraction is a prognostic factor in stage I breast carcinoma J Clin Oncol 11 1717–1722 Occurrence Handle1:STN:280:ByyA2Mbpt1Q%3D Occurrence Handle8355038
CR Wenger S Beardslee MA Owens G Pounds T Oldaker P Vendely MR Pandian D Harrington GM Clark WL McGuire (1993) ArticleTitleDNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients Breast Cancer Res Treat 28 9–20 Occurrence Handle10.1007/BF00666351 Occurrence Handle1:STN:280:ByuC28bjvF0%3D Occurrence Handle8123871
P Vielh S Chevillard V Mosseri B Donatini H Magdelenat (1990) ArticleTitleKi67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors Am J Clin Pathol 94 681–686 Occurrence Handle1:STN:280:By6D2Mfht1M%3D Occurrence Handle2244589
H Romero J Schneider J Burgos J Bilbao FJ Rodriguez-Escudero (1996) ArticleTitleS-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers Breast Cancer Res Treat 38 265–275 Occurrence Handle1:STN:280:BymA38flslw%3D Occurrence Handle8739079
J Schneider M Pollan A Ruibal E Jimenez AR Lucas MI Nunez N Sanchez A Tejerina (1999) ArticleTitleHistologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer Tumour Biol 20 319–330 Occurrence Handle10.1159/000030096 Occurrence Handle1:STN:280:DC%2BD3c%2Fjs1yktw%3D%3D Occurrence Handle10567878
F Martinez-Arribas MJ Nunez V Piqueras AR Lucas J Sanchez A Tejerina J Schneider (2002) ArticleTitleFlow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases Anticancer Res 22 295–298 Occurrence Handle1:STN:280:DC%2BD383ns1Wmtg%3D%3D Occurrence Handle12017306
KW Gilchrist R Gray AM Driel-Kulker WE Mesker JJ Ploem-Zaaijer JS Ploem SG Taylor DC Tormey (1993) ArticleTitleHigh DNA content and prognosis in lymph node positive breast cancer. A case–control study by the University of Leiden and ECOG. (Eastern Cooperative Oncology Group). Breast Cancer Res Treat 28 1–8 Occurrence Handle10.1007/BF00666350 Occurrence Handle1:STN:280:ByuC28bjvFY%3D Occurrence Handle8123866
AE Pinto S Andre E Mendonca G Silva J Soares (2003) ArticleTitleOverall survival in advanced breast cancer: relevance of progesterone receptor expression and DNA ploidy in fine-needle aspirates of 392 patients Int J Biol Markers 18 IssueID1 7–12 Occurrence Handle1:CAS:528:DC%2BD3sXlvVSrsbo%3D Occurrence Handle12699057
OP Kallioniemi T Visakorpi K Holli JJ Isola PS Rabinovitch (1994) ArticleTitleAutomated peak detection and cell cycle analysis of flow cytometric DNA histograms Cytometry 16 250–255 Occurrence Handle1:STN:280:ByqD3cbhvF0%3D Occurrence Handle7924694
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martinez-Arribas, F., Nuñez-Villar, M.J., Lucas, A.R. et al. The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers. Breast Cancer Res Treat 92, 77–80 (2005). https://doi.org/10.1007/s10549-005-2114-9
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-2114-9